Clinical Trial Update: A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and anti-HIV activity of HE2000 in HIV-infected patients on salvage therapy; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HE2000

Snippet

Sponsor: Harbor Therapeutics | Conditions: HIV Infections | Phase 1 | Status: COMPLETED